Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses?

Dopamine receptors and related signaling pathways have long been implicated in pathophysiology and treatment of mental illnesses, including schizophrenia and bipolar disorder. Dopamine signaling may impact neuronal activity by modulation of glutamate neurotransmission. Recent evidence indicates a direct and/or indirect involvement of fragile X-related family proteins (FXR) in the regulation and mediation of dopamine receptor functions. FXRs consists of fragile X mental retardation protein 1 (Fmr1/FMRP) and its autosomal homologs Fxr1 and Fxr2. These RNA-binding proteins are enriched in the brain. Loss of function mutation in human FMR1 is the major genetic contributor to Fragile X mental retardation syndrome. Therefore, the role of FXR proteins has mostly been studied in the context of autism spectrum disorders. However, recent genome-wide association studies have linked this family to schizophrenia, bipolar disorders, and mood regulation pointing toward a broader involvement in mental illnesses. FXR family proteins play an important role in the regulation of glutamate-mediated neuronal activity and plasticity. Here, we discuss the brain-specific functions of FXR family proteins by focusing on the regulation of dopamine receptor functions, ionotropic glutamate receptors-mediated synaptic plasticity and contribution to mental illnesses. Based on recent evidence, we propose that FXR proteins are potential integrators of dopamine signaling and ionotropic glutamate transmission.

• Publication year

  2018

• Venue

  Frontiers in Synaptic Neuroscience

• Publication date

  2018-07-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fnsyn.2018.00022PMID 30087606PMCID 6066532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein expression

  2020cited by this paper
• Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3β Are Modulators of Anxiety and Glutamatergic Neurotransmission

  2018influential reference
• Genome-wide identification of splicing QTLs in the human brain and their enrichment among schizophrenia-associated loci

  2017cited by this paper
• The interaction of GSK3B and FXR1 genotypes may influence the mania and depression dimensions in mood disorders.

  2017cited by this paper
• Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia

  2017cited by this paper
• Inhibition of the Schizophrenia-Associated MicroRNA miR-137 Disrupts Nrg1α Neurodevelopmental Signal Transduction.

  2017influential reference
• The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment

  2017cited by this paper
• Correlated expression analysis of genes implicated in schizophrenia: identification of putative disease-related pathways.

  2016influential reference
• Analyzing the Role of MicroRNAs in Schizophrenia in the Context of Common Genetic Risk Variants.

  2016cited by this paper
• A genome-wide association study of bipolar disorder with comorbid eating disorder replicates the SOX2-OT region

  2016cited by this paper
• A genome-wide association study of bipolar disorder with comorbid eating disorder replicates the SOX2-OT region.

  2016cited by this paper
• Exome Sequencing of Familial Bipolar Disorder.

  2016cited by this paper
• Tracking the Fragile X Mental Retardation Protein in a Highly Ordered Neuronal RiboNucleoParticles Population: A Link between Stalled Polyribosomes and RNA Granules

  2016cited by this paper
• G protein-coupled receptor kinases as regulators of dopamine receptor functions.

  2016cited by this paper
• Fragile X Proteins FMRP and FXR2P Control Synaptic GluA1 Expression and Neuronal Maturation via Distinct Mechanisms.

  2015cited by this paper
• FXR1P is a GSK3β substrate regulating mood and emotion processing

  2015cited by this paper
• Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers

  2015cited by this paper
• C57BL/6N mutation in Cytoplasmic FMR interacting protein 2 regulates cocaine response

  2015cited by this paper
• Protein expression of targets of the FMRP regulon is altered in brains of subjects with schizophrenia and mood disorders.

  2015cited by this paper
• Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes

  2015cited by this paper
• Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration.

  2014cited by this paper
• De novo mutations in schizophrenia implicate synaptic networks

  2014cited by this paper
• A polygenic burden of rare disruptive mutations in schizophrenia

  2014cited by this paper
• Biological Insights From 108 Schizophrenia-Associated Genetic Loci

  2014cited by this paper
• MicroRNA-9 and MicroRNA-326 Regulate Human Dopamine D2 Receptor Expression, and the MicroRNA-mediated Expression Regulation Is Altered by a Genetic Variant*

  2014cited by this paper
• FXR1P limits long-term memory, long-lasting synaptic potentiation, and de novo GluA2 translation.

  2014cited by this paper
• An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex

  2014cited by this paper
• Long-Term Abstinence from Developmental Cocaine Exposure Alters Arc/Arg3.1 Modulation in the Rat Medial Prefrontal Cortex

  2014cited by this paper
• Genome wide assessment of mRNA in astrocyte protrusions by direct RNA sequencing reveals mRNA localization for the intermediate filament protein nestin

  2013cited by this paper
• Decreased fragile X mental retardation protein (FMRP) is associated with lower IQ and earlier illness onset in patients with schizophrenia.

  2013cited by this paper
• C57BL/6N Mutation in Cytoplasmic FMRP interacting protein 2 Regulates Cocaine Response

  2013cited by this paper
• The role of fragile X mental retardation protein in ovarian development and oogenesis

  2013cited by this paper
• Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour

  2012cited by this paper
• Glycogen Synthase Kinase-3: A Promising Therapeutic Target for Fragile X Syndrome

  2011cited by this paper
• Fragile X Related Protein 1 Clusters with Ribosomes and Messenger RNAs at a Subset of Dendritic Spines in the Mouse Hippocampus

  2011cited by this paper
• FXR1P But Not FMRP Regulates the Levels of Mammalian Brain-Specific microRNA-9 and microRNA-124

  2011influential reference
• The Physiology, Signaling, and Pharmacology of Dopamine Receptors

  2011cited by this paper
• Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder

  2011cited by this paper
• The role of fragile X mental retardation protein in major mental disorders.

  2011cited by this paper
• Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.

  2010cited by this paper
• Roles of Fragile X Mental Retardation Protein in Dopaminergic Stimulation-induced Synapse-associated Protein Synthesis and Subsequent α-Amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) Receptor Internalization*

  2010cited by this paper
• Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs

  2009cited by this paper
• Akt/GSK3 signaling in the action of psychotropic drugs.

  2009cited by this paper
• The FXG: A Presynaptic Fragile X Granule Expressed in a Subset of Developing Brain Circuits

  2009cited by this paper
• The dopamine hypothesis of schizophrenia: version III--the final common pathway.

  2009cited by this paper
• Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.

  2009cited by this paper
• The dopamine hypothesis of schizophrenia.

  2009cited by this paper
• FMRP acts as a key messenger for dopamine modulation in the forebrain.

  2008cited by this paper
• ΔFosB Mediates Epigenetic Desensitization of the c-fos Gene After Chronic Amphetamine Exposure

  2008cited by this paper
• Altered gene expression in the superior temporal gyrus in schizophrenia

  2008cited by this paper
• Epigenetic mechanisms in drug addiction.

  2008cited by this paper
• Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.

  2006cited by this paper
• An Akt /-Arrestin 2 / PP 2 A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior

  2005influential reference
• Localization of FMRP‐associated mRNA granules and requirement of microtubules for activity‐dependent trafficking in hippocampal neurons

  2005cited by this paper
• DARPP-32: an integrator of neurotransmission.

  2004cited by this paper
• Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo.

  2004cited by this paper
• Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex

  2004cited by this paper
• Modulation of Synaptic Plasticity by Antimanic Agents: The Role of AMPA Glutamate Receptor Subunit 1 Synaptic Expression

  2004cited by this paper
• Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade.

  2004cited by this paper
• Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity.

  2004cited by this paper
• Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice

  2003cited by this paper
• Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice.

  2003cited by this paper
• Knockout mouse model for Fxr2: a model for mental retardation.

  2002cited by this paper
• FMR1 and the fragile X syndrome: Human genome epidemiology review

  2001cited by this paper
• Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse.

  2000cited by this paper
• Regulation of Phosphorylation of the GluR1 AMPA Receptor in the Neostriatum by Dopamine and Psychostimulants In Vivo

  2000cited by this paper
• Dopamine receptors: from structure to function.

  1998cited by this paper
• Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis.

  1997cited by this paper
• A b-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior

  year unknowncited by this paper

• Deep Proteome Profiling of Rat Dorsal Striatal Synaptoneurosomes Following Methamphetamine Exposure.

  2025cites this paper
• Free D-aspartate modulates the expression of proteins linked to schizophrenia and autism spectrum disorder during early postnatal life

  2025cites this paper
• Analysis of single-cell transcriptome data from a mouse model implicates protein synthesis dysfunction in schizophrenia

  2024cites this paper
• Striatal increase of dopamine receptor 2 density in idiopathic and syndromic mouse models of autism spectrum disorder

  2023cites this paper
• Glutamatergic Neurotransmission: A Potential Pharmacotherapeutic Target for the Treatment of Cognitive Disorders.

  2023cites this paper
• Combining affinity purification and mass spectrometry to define the network of the nuclear proteins interacting with the N-terminal region of FMRP

  2022cites this paper
• Whole Transcriptome Sequencing Identified CircRNA Profiles and the Related Networks in Schizophrenia

  2022cites this paper
• Methylome-wide change associated with response to electroconvulsive therapy in depressed patients

  2021cites this paper
• Evidence of an interaction between FXR1 and GSK3β polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychotics

  2021cites this paper
• Altered dopaminergic pathways and therapeutic effects of intranasal dopamine in two distinct mouse models of autism

  2020cites this paper
• Evidence for enhancer noncoding RNAs (enhancer-ncRNAs) with gene regulatory functions relevant to neurodevelopmental disorders

  2020cites this paper
• miR-132 Regulates PTSD-like Behaviors in Rats Following Single-Prolonged Stress Through Fragile X-Related Protein 1

  2020cites this paper
• Fxr1 regulates sleep and synaptic homeostasis

  2019cites this paper
• Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects

  2019cites this paper
• Quantitative proteomics of forebrain subcellular fractions in fragile X mental retardation 1 knockout mice following acute treatment with 2‐Methyl‐6‐(phenylethynyl)pyridine: Relevance to developmental study of schizophrenia

  2018cites this paper